Asset Publisher

Rare disease gives new insight into regulatory T-cell function

Rare disease gives new insight into regulatory T-cell function

An international study led by researchers at CMM provides new insights into the regulatory T cells’ role in protecting against autoimmune disease. By mapping the targets of the immune system in patients with the rare disease IPEX, they were able to show that regulatory T cells control immunotolerance in the gut.

The researchers took advantage of a method that makes it possible to examine the immune response against 9,000 proteins in parallel.

“Our study is the first large-scale assay of how the immune system attacks the organs of IPEX patients,” says first author Daniel Eriksson to KI News.

“We hope that our results will make it easier to diagnose patients with IPEX and monitor them during treatment,” says Nils Landegren, the study’s last author.

Daniel Eriksson and Nils Landegren. Photo: Fabian Sardh. 

The study The autoimmune targets in IPEX are dominated by gut epithelial proteins was published in Journal of Allergy and Clinical Immunology, online 23 April 2019.

Read more at Karolinska Institutet website.

NEWS

Susanna Brauner Awarded the Swedish Society of Medicine's Translational Research Prize

Susanna Brauner Awarded the Swedish Society of Medicine's Translational Research Prize Susanna Brauner , Assistant professor and CMM researcher (Fredrik Piehl’s Team) has received the...

Ning Xu Landén 2020 year’s winner of the LEO Foundation Award

Ning Xu Landén 2020 year’s winner of the LEO Foundation Award Associate Professor Ning Xu Landén, Group Leader at CMM is the winner of this year’s LEO Foundation Award in Region EMEA...

Nils Landegren receives ERC Starting Grant for studying sex differences in the human immune system

Nils Landegren receives ERC Starting Grant for studying sex differences in the human immune system Photo: Hans Ericksson, SSMF Nils Landegren , Researcher at CMM, has been awarded...

Verification project of SARS-CoV-2 antibody tests receives funding from Swelife

Verification project of SARS-CoV-2 antibody tests receives funding from Swelife Photo: Mattias Bronge, Karolinska Institutet A validation project of new SARS-CoV-2 antibody tests,...

Grant to Qiaolin Deng for the single-cell technology core at CMM

Grant to Qiaolin Deng for the single-cell technology core at CMM Qiaolin Deng, private photo We congratulate Associate Professor and CMM Team Leader Qiaolin Deng who received a SFO...

Identification of key gene for improvement of multiple sclerosis treatments

Identification of key gene for improvement of multiple sclerosis treatments Karl Carlström and Fredirk Piehl. Photo: Stefan Zimmermann   CMM researcher Karl Carlström and...

Sweden’s innovation agency Vinnova extends the funding of Genomic Medicine Sweden with additional SEK 36 million

Sweden’s innovation agency Vinnova extends the funding of Genomic Medicine Sweden with additional SEK 36 million Sweden’s innovation agency Vinnova extends the funding of the national...

The Swedish Heart-Lung Foundation major grant 2020 goes to Marie Wahren-Herlenius

The Swedish Heart-Lung Foundation major grant 2020 goes to Marie Wahren-Herlenius Professor Marie Wahren-Herlenius, Group Leader at CMM, has received the biggest yearly grant in Sweden...

Simple blood test may help predict MS progression, study finds

Simple blood test may help predict MS progression, study finds Photo: Ali Manouchehrinia   A study led by the CMM researchers Ali Manouchehrinia (first...

Experimental study finds new substances with higher specificity and therapeutic potential in multiple sclerosis

Experimental study finds new substances with higher specificity and therapeutic potential in multiple sclerosis   Karl Carlström, photo Stefan Zimmerman   Karl...